Saturday 17 October 2026
Export LNTH’s income statement to Excel — free account
Lantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024. In the quarter to June 2026, revenue grew 2.68%, EPS was flat, free cash flow grew 13.6% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years.
99.70
0.29
−0.29%
Follow LNTH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 5 |
+8 more TTM periods Free account |
| 22.21% | 23.48% | 21.45% | 14.59% | ||
| 12.15% | 12.68% | 11.10% | 7.75% | ||
ROIC |
14.65% | 14.12% | 14.94% | 16.63% | |
Return on Tangible Assets |
32.59% | 36.39% | 31.98% | 22.59% | |
Average Days of Receivables |
83.04 | 84.31 | 88.56 | 91.67 | |
Free Cash Flow per Share |
6.03 | 5.90 | 5.25 | 6.30 | |
Free Cash Flow |
392.83 | 382.11 | 354.05 | 423.79 | |
Capital Expenditures |
(19.97) | (25.60) | (36.09) | (33.90) | |
| Other line items | |||||
Cash ROIC |
15.86% | 16.75% | 17.54% | 20.47% | |
Accounts Receivable Turnover |
4.51 | 4.38 | 4.38 | 4.28 | |
Accounts Payable Turnover |
13.94 | 13.47 | 15.48 | 10.36 | |
Inventory Turnover |
10.36 | 9.37 | 9.04 | 8.67 | |
Average Days of Payables |
28.31 | 27.40 | 26.12 | 41.99 | |
Days of Inventory on Hand |
33.86 | 36.64 | 39.37 | 39.29 | |
Tax Rate |
(0.24) | (0.25) | (0.26) | (0.31) | |
Research and Development Expense of Revenue |
11.12% | 11.67% | 11.50% | 10.82% | |
Selling, General and Administrative Expense of Revenue |
29.60% | 30.06% | 29.44% | 28.78% | |
Share Based Compensation of Revenue |
5.02% | 5.20% | 5.55% | 5.91% | |
Interest Coverage |
15.26 | 14.64 | 15.74 | 17.63 | |
Operating CF/Net income |
1.50 | 1.46 | 1.67 | 2.73 | |
Depreciation/Fixed assets |
0.61 | 0.53 | 0.46 | 0.42 | |
Capex/Depreciation |
(0.21) | (0.31) | (0.48) | (0.49) | |
Revenue per Share |
23.88 | 23.88 | 22.84 | 22.70 | |
Operating CF per Share |
6.34 | 6.30 | 5.78 | 6.81 | |
Capex per Share |
(0.31) | (0.40) | (0.53) | (0.50) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.02 |
Columns are period end dates